Assyro AI

FDA Orange Book · active-ingredient family

Azelastine hydrochloride; fluticasone propionate

Azelastine hydrochloride; fluticasone propionate is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DYMISTA · NDA 202236

1

Brand (NDA)

3

Generics (ANDA)

2

Listed patents

0

Exclusivity periods

Brand (NDA) products · spray, metered

ProductApplicantApplicationTEApproved
DYMISTARLDMYLAN SPECIALITY LPNDA 202236ABMay 01, 2012

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATETEVA PHARMS USA INCANDA 208436ABApr 08, 2025
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATEPADAGIS ISRAELANDA 208111ABFeb 18, 2021
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATEAPOTEXANDA 207712ABApr 28, 2017

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8168620Feb 24, 20264 mo ago
Product
8168620*PEDAug 24, 2026in 2 mo

Azelastine hydrochloride; fluticasone propionate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.